A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...